

























































Release of Soybean Isoflavones by Using a β-Glucosidase
from Alicyclobacillus herbarius
Lidia Delgado+,[a] Christian M. Heckmann+,[a] Flavio Di Pisa,[b] Louise Gourlay,[b] and
Francesca Paradisi*[a, c]
β-Glucosidases are used in the food industry to hydrolyse
glycosidic bonds in complex sugars, with enzymes sourced
from extremophiles better able to tolerate the process con-
ditions. In this work, a novel β-glycosidase from the acidophilic
organism Alicyclobacillus herbarius was cloned and heterolo-
gously expressed in Escherichia coli BL21(DE3). AheGH1 was
stable over a broad range of pH values (5–11) and temperatures
(4–55 °C). The enzyme exhibited excellent tolerance to fructose
and good tolerance to glucose, retaining 65% activity in the
presence of 10% (w/v) glucose. It also tolerated organic
solvents, some of which appeared to have a stimulating effect,
in particular ethanol with a 1.7-fold increase in activity at 10%
(v/v). The enzyme was then applied for the cleavage of
isoflavone from isoflavone glucosides in an ethanolic extract of
soy flour, to produce soy isoflavones, which constitute a
valuable food supplement, full conversion was achieved within
15 min at 30 °C.
Introduction
β-Glucosidases (EC 3.2.1.21) constitute a group of enzymes that
hydrolyse terminal, non-reducing glycosyl residues from
glycosides.[1] These enzymes have been successfully applied in a
broad range of industrial applications,[2] and they have become
key tools to hydrolyse very stable glycosidic bonds in a clean
and efficient way.
However, many food industrial processes involve harsh
conditions (high concentrations of solvents and sugars, low pH
and high temperatures) that can inactivate enzymes.[3,4] Extrem-
ophiles are organisms well adapted to extreme environmental
conditions[5] and they constitute a novel and alternative source
of enzymes (extremozymes) for industrial applications. Extrem-
ozymes are generally more resistant in demanding industrial
processes when compared to mesophilic enzymes.[6]
Soybean (Glycine max) originating in China, constitutes one
of the largest sources of vegetable oil in the world and has the
highest protein content among all others food crops.[7] Its
consumption has become increasingly popular in recent years
as it is an excellent protein source for the human diet. In
addition, soybean contains several compounds considered
important food supplements due to their health properties,
especially isoflavones. Soybeans mainly contain three types of
isoflavones (daidzein, genistein, and glycitein), which can be
found in four different forms (Figure 1): as aglycons, 7-O-β-d-
glucosides, 7-O-(6’’-O-acetyl)glucosides, or 7-O-(6’’-O-malonyl)
glucosides.[8] Recently, commercial preparations of isoflavones
have come to the public attention following studies on their
reported positive effects on cognitive function.[9] However,
when the biological activities of these compounds are consid-
ered, the bioavailability of the aglycone has been suggested to
be higher than that of the glycoside; but it represents only a
minor constituent of unfermented soy products.[10]
β-Glucosidases can be used to hydrolyse isoflavone gluco-
sides to their aglycons. The industrial processing for extracting
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Figure 1. Structure of the main isoflavone glucosides (glycitin, genistin, and
daidzin) found in soybean. The isoflavone moiety (glycitein, genistein, and
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isoflavones from soybeans includes the use of organic solvents
(mostly ethanol) which is necessary to solubilise the
isoflavones.[11] Soy isoflavones are released as a side-product
during the industrial fermentation process for the production of
erythromycin, using the microorganism Saccharopolyspora
erythraea (by endogenous β-glucosidases). However, the iso-
flavone aglycones themselves are metabolised by that organ-
ism, requiring either metabolic engineering or subsequent
enzymatic treatment (or acid hydrolysis) of the spent broth to
obtain the aglycon.[12–14] The use of purified β-glucosidases for
isoflavone aglycon production from soy flour has also been
investigated, in particular from the thermophilic bacteria
Thermotoga maritima and Thermoanaerobacter ethanolicus
JW200. However, these enzymes required defatting of the soy
flour using hexane (an undesirable neurotoxic solvent[15]) and
high reaction temperatures (65–80 °C).[16,17] The use of a GH1 β-
glucosidase from Alicyclobacillus sp. A4 as a supplement in soy-
based animal feed to aid in the release of the aglycon in
monogastric animals has also been investigated under milder
conditions (37 °C), but in the absence of the co-solvents
required for extracting the aglycons.[18] Again, many β-glucosi-
dases reported to date from mesophilic organisms are inhibited
by both organic solvents.[19] and glucose,[20,21] which would be
present at increasing concentrations as the hydrolytic process
progresses.
In this work, a novel β-glucosidase (WP_026963033.1) of the
glycosyl hydrolase family 1 (GH1) from the extremophilic
organism Alicyclobacillus herbarius (Ahe) has been identified and
investigated. Ahe was first isolated from a herbal tea made from
dried flowers of hibiscus, it has been described as a thermo-
acidophilic Gram-positive bacterium that grows at a range of
temperatures between 35–65 °C and a pH between 3.5 and 6,
features that are very appealing for different applications in the
food industry market.[22] The enzyme has been cloned and
expressed in Escherichia coli, its crystal structure has been
solved and the enzyme has been characterised to assess its
performance under different operational conditions (glucose,
fructose, organic co-solvents and range of pH values and
temperatures) usually found in food industrial processes.
Following the initial characterisation, AheGH1 has been applied
to hydrolyse the main isoflavone glucosides present in soybean
flour.
Results and Discussion
Protein expression and purification
AheGH1 was expressed and purified with excellent yields
between 75–100 mg/L of culture. The purification, by metal
affinity chromatography, was analysed by SDS-PAGE (Figure S1
in the Supporting Information). AheGH1 has a theoretical
monomeric molecular weight of 52133.66 Da (�52 kDa) esti-
mated by the online tool ProtParam[23] and sufficient degree of
purification was confirmed by SDS-PAGE. The molecular weight
was determined to be 99.7 KDa by gel filtration, consistent with
it being a dimer in solution (Figure S2 and Table S1).
The 3D structure of AheGH1
Crystals of AheGH1 enzyme belonging to the monoclinic space
group P21 diffracted at 1.98 Å resolution. The asymmetric unit
of AheGH1 contains four independent molecules, with a
calculated Matthews coefficient of 2.42 Å3 Da1 (estimated
solvent content of 49.31%; Figure 2). The overall structure of
the four AheGH1 subunits is identical (RMSD values of 0.05 to
0.08 Å over 356 backbone Cα atoms).
The final model was refined to R values of Rwork 24.7% and
Rfree 29.8%. The presence of strong translational noncrystallo-
graphic symmetry (tNCS), as confirmed by a peak in the
Patterson map, may justify the higher than expected final Rwork
value, despite the high resolution of the structure (Table S2).
Electron density map was overall of good quality, with electron
density coverage across residues 2-450 (chain A), 2-451 (chain
B), 3-447, (chain C) and 3-446 (chain D), except for a short
stretch (P304-D322). Several ethylene glycol molecules derived
from the crystallisation buffer were modelled into the electron
density. In addition, two nickel cations were identified in the
model, present during the affinity chromatography purification
step. The metal cations are located at the dimer interfaces
between chain A and the symmetry-related monomer C and
between the B and D subunits and are coordinated in a
tetrahedral arrangement by the side chains contributed from
two histidine (H61) and two glutamate (E29) residues.
AheGH1 is arranged into a single (β/α)8 barrel fold, common
to this family of glycosidases, with negligible main-chain
displacements in peripheral loops and α-helices. Regions which
show more significative changes in the secondary structure
correspond to residues 272 to 281, folded into a gamma and
two β-turns, and residues 409 to 416 that form two β-turns
instead of the more common α-helices (Figure 2).
A feature of the GH1 family is that despite low sequence
identity (as low as 17%) they share high structure conservation.
3D structure-based comparisons performed with the DALI
server (http://ekhidna2.biocenter.helsinki.fi/dali/)[24] revealed
that the AheGH1 protein has the highest structural similarity
with a family 1 glucoside hydrolase from Paenibacillus polymyxa
(BglB; PDB ID: 2O9P).[25] Despite average sequence identity
(52%), superposition between the two proteins revealed a high
Figure 2. 3D structure of AheGH1. A) The AheGH1 tetramer present in the
asymmetric unit. B) Top and side views of the AheGH1 monomer, with
ribbons coloured according to secondary structure (β-strands in orange, α-
helices in green, 3-, 4- and 5-turns in yellow, unstructured regions in grey).
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degree of structural similarity (RMSD of 0.6 Å) over 441 aligned
residues.
The AheGH1 active site
An enzyme template search of catalytic site templates made
with the ProFunc server (http://www.ebi.ac.uk/thornton-srv/
databases/ProFunc),[26] identified the cyanogenic family 1 glyco-
syl hydrolase (CBG) from white clover (PDB ID: 1CBG)[27] as the
top hit. AheGH1 and CBG share low (36.94%) overall sequence
identity, yet high (73.47%) local sequence identity in their
active sites over 49 equivalenced residues. At a structural level,
they share high structural similarity (99.5% over 493 matched
residues) and as for AheGH1, CBG is a homodimer in solution.[27]
In agreement with CBG and other GH1 members in general, the
active site pocket contains several conserved polar and
aromatic residues that are typically present in carbohydrate
recognition sites that binds the nonreducing end of the
substrate.[21] Based on comparisons with GH1 members, AheGH1
the main active site residues present are: R79, H122, E167,
N166, N296, Y298, E356 and W402 (Figures 3 and S3+4).
The mechanism of catalysis generally described for this class
of enzyme involves a double displacement reaction, requiring a
proton donor and a nucleophile.[27] Previous results are
consistent with an ionised carboxylic acid group acting as a
catalytic nucleophile and a histidine residue or carboxylic acid
group (with a significantly elevated pKa) behaving as a general
acid catalyst. Based on comparisons made with GH1 members
in general, E167 and E356 are likely to be the acid-base catalyst
and nucleophile, respectively in the reaction (Figures 3 and S4).
With regards to the active site architecture of GH1 enzymes
in general, structural and thus functional differences are
attributed to the loop regions that are present between the β/α
motifs that shape the active site cavity. This may be appreciated
by comparison of the overall sequence and structure conserva-
tion of AheGH1 with all other enzymes of similar structure,
using the ENDscript 2 server (http://endscript.ibcp.fr/ESPript/
ENDscript/).[28] As expected, structure and sequence divergence
occurs mainly in the loop regions connecting the β/α motifs
(Figure S3).
In BlgB, nine active-site residues are reported to delineate
the entrance to the active site: Y169, T178, E180, R243, E225,
Q316, H318, W328 and W412 (BlgB numeration).[25] These
residues render the active site cavity narrower in comparison
with its homologue BglA (PDB ID: 1E4Y).[29] Except for W328, all
remaining residues in AheGH1 are not conserved (Figure S4).
Higher similarity, in terms of sequence identity, was on the
other hand detected between AheGH1 and the BglA active site,
defined by residues W168, L177, V179, S224, T242, E314, N316,
W326 and E408. Three out of the nine residues (i. e., W168, V179
and W326; Figure S4) are conserved between the two proteins.
In addition, according to the nature and steric hindrance of the
side-chains of the residues defining the active site, the AheGH1
cavity is more similar to that of BglA.
Activity assay and kinetic parameters
The activity assay was performed spectrophotometrically using
p-nitrophenyl-β-d-glucopyranoside (pNPG) at 25 °C. 10 μL of the
suitable dilution of the enzyme was added to a 96-well plate in
triplicate together with 0.29 mL of the reaction solution pNPG
(10 mM), HEPES (50 mM), pH 7.4. The p-nitrophenol formation
was followed for 10 minutes at 420 nm. The enzyme showed a
specific activity of 20 Umg  1. AheGH1 also showed activity with
p-nitrophenyl-β-d-fucopyranoside, -galactopyranoside, and -xy-
lopyranoside. While the activity with the fucoside was un-
changed, it was reduced by approximately 30% for the galacto-
side and 98% for the xyloside (Figure 4A).
The kinetic parameters of AheGH1 for pNPG were deter-
mined under the same conditions of the activity assay but using
different substrate concentrations.[31] Km (1.4�0.1 mM), Ki (37�
6 mM) and kcat (2.7�0.1 s
  1) were calculated in triplicate by
nonlinear regression using GraphPad Prism 8 (Figure 4B; see the
Experimental Section for details).
Figure 3. The AheGH1 active site. A) The AheGH1 putative active site
showing active-site residues delineating the pocket (sticks). Proposed
catalytic resides E356 and E167 are indicated. B) Structural superposition of
the active sites of AheGH1 (blue) and the homologous protein BglA (gold;
PDB ID: 1E4I) complexed with 2-deoxy-2-fluoro-α-d-glucopyranose catalytic
intermediate (yellow sticks) and C) superposition of AheGH1 (ice blue) with
BglA (yellow) and BglB (pink) in complex with glucose (PDB ID: 2O9T) and a
detailed view of the glucose binding site. Glucose is shown as black sticks.
BglB residues interacting with the glucose molecule, and the corresponding
AheGH1 residues, are depicted as sticks and coloured accordingly. AheGH1
residues conserved in BglA are coloured in purple. AheGH1 W329, which is
conserved in all the three homologues is coloured in orange. Residue
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A thorough characterisation of this novel enzyme was per-
formed, to probe the activity and stability in the presence of
sugars, solvents, different pH values and different temperatures.
Activity assays
The effect of glucose, fructose and a different range of co-
solvents is reported in Figure 4.
Glucose inhibition (Figure 4C) is a common problem among
β-glucosidases,[21,32] as the accumulation of the product of the
hydrolytic process naturally reduces the catalytic efficiency of
the enzyme. However, it has been reported that some β-
glucosidases belonging to the family GH1 can be exceptionally
tolerant or even stimulated by glucose, but the mechanism of
that tolerance/stimulation is still not clear.[3,18,33] The structure of
BglB in complex with glucose (PDB ID: 2O9T)[25] has been solved;
the residues involved in ligand binding (Q22, H122, N166, E157,
H181, E365, W410, E409, W412:BglB numbering) are conserved
in AheGH1 (Figure 3C). A mechanism of product inhibition,
whereby the glucose molecule remains tightly bound to the
active site until it is displaced by the arrival of a new substrate
molecule, has been suggested for a plant β-d-glucan glucohy-
drolase GH3 enzyme.[34] Further studies to assess the behaviour
of AheGH1 in the presence of glucose were carried out. A broad
range of glucose concentrations, from 0.1 to 25% (w/v), were
evaluated, showing that the AheGH1 activity slowly decreases
as the concentration of glucose increases. With 25% (w/v) of
glucose in the reaction, AheGH1 retains 30% of its activity. In
contrast, the β-glucosidase from Aspergillus niger, a glycosidase
commonly used in food industrial processes, only retains 2%
activity in the presence of 10% (w/v) glucose in the mixture.[35]
Fructose (Figure 4C) has a milder effect on the enzyme activity
than glucose. The retained activity varies between 80%, with
5% (w/v) of fructose, and 67%, with 25% of fructose in the
reaction mixture. It is unclear whether the effect of fructose is
due to inhibition or caused by the two- to threefold increase in
viscosity as concentration increases.[36]
Commonly, many enzymes from mesophilic organisms are
significantly destabilised by organic solvents. This could be
attributed to the loss of crucial water molecules that maintain
the protein conformation (desolvation), affecting the Km and
vmax values, and, in the most dramatic cases the overall protein
folding. Retained activity in the presence of organic solvents is
possible only when the protein surface and the active site
remain well hydrated. AheGH1 presents an impressive co-
solvent tolerance, retaining over 50% activity in all cases
(Figure 4D). Particularly relevant for the intended application of
Figure 4. A) Specific activity with various pNP-glucosides. B) Substrate inhibition kinetics with pNPG. Effects of C) glucose and fructose and D) co-solvents on
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this enzyme, is its performance in the presence of ethanol
which is one of the most common solvents in food processing;
with 10 and 20% of ethanol in the reaction mix, AheGH1 is 50%
more active than without ethanol at all. This behaviour has
been previously reported for other glucosidases in literature.[37]
Stability assays
Enzyme long term stability is also a key parameter to assess the
potential implementation of the catalyst in biotechnological
processes. Results for the AheGH1 stability assay in the presence
of co-solvents and a different range of temperatures and pH
values have been evaluated.
When the enzyme is incubated with co-solvents (Figure 5), a
very stable behaviour over significant period of time is
observed. AheGH1 retains over 55% activity after 48 h incuba-
tion in all 12 conditions.
The results obtained for the enzymatic stability at a different
pH values (Figure S5) showed that AheGH1 is stable between
pH 5 and 11, less active at pH 4 and 12 and completely unstable
at pH 3. The enzyme shows no activity at pH 3 despite being
selected from an acidophilic organism. Indeed, the ability of the
source microorganism in dealing with acidic pH does not
always translate to the isolated catalyst. Most adaptation
mechanisms developed by acidophiles to survive at low pH
involve very efficient homeostasis which prevents the ingress of
protons to the cytoplasm.[38] Consequently, the cytoplasmatic
enzymes of those organism do not necessarily deal with acidic
conditions and hence are not adapted to it.
Regarding stability at different temperatures (Figure S6),
AheGH1 retains above 40% activity from 4 up to 55 °C, covering
the usual range of temperatures of food industrial processes.
This is lower than for the GH1 from thermoacidophile
Alicyclobacillus acidocaldarius (WP_008336965.1; 52%
identity),[39] which was stable at up to 65 °C. On the other hand,
the aforementioned BglB of P. polymyxa has a half-life of
2.7 min at 55 °C. Arrizubieta and Polaina[40] reported four
mutations (three residues) that enhance its thermostability,
H62R, M319I/V and M361I, with H62 M resulting in the largest
increase in thermostability. The equivalent residues in AheGH1
are R62, A319 and F361 (see the Supporting Information). Thus,
the most significant mutation in BglB is mirrored and the other
two residues are altered, which might contribute to the
enhanced thermostability of AheGH1. Yet, while the authors
propose a salt-bridge between R62 and E429 in BglB, the
equivalent residue in AheGH1 is Q429.
The thermal stability of AheGH1 was measured in thermo-
fluorimetry studies, following the increase in fluorescence
intensity (λex=470–505 nm; λem =540–700 nm) that arises due
to the binding of the fluorophore SYPRO™Orange to internally
located hydrophobic residues of the protein, that become
exposed during thermal denaturation (see the Experimental
Section). AheGH1 unfolded in a single step, with a melting
temperature (Tm) of 67 °C (Figure S7). This is approximately 10 °C
higher than what has been reported for wild-type BglB,[41,42]
further confirming the increased thermostability of AheGH1.
Activity of AheGH1 with isoflavone glucosides
The hydrolytic activity of AheGH1 towards three isoflavones
glucosides (daidzin, glycitin, genistin) was assessed over
15 minutes incubation at 30 °C (Figure 6). At the control
reaction, where no enzyme was added, no hydrolysis occurred,
and the three isoflavone glucosides remained intact. When
Figure 5. Effect of incubation in different co-solvents on AheGH1 stability. The activity was tested in a standard activity assay at 25 °C. Activity expressed
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AheGH1 was added to the reaction, 100% conversion to the
correspondent aglycons, daidzein, glycitein and genistein was
consistently achieved. It is important to highlight that this
hydrolysis occurs in the presence of 30% DMSO in addition to
15% ethanol present in the reaction, as both solvents have
been used to solubilise the isoflavone glucosides in their stock
solutions. These results are in line with the findings from the
activity and stability assays in the presence of different co-
solvents explained above.
Performance of AheGH1 over soybean flour
Following the initial testing of AheGH1 with the synthetic
isoflavone glucosides, the performance of the enzyme was
tested with a real isoflavone mixture extracted from soybean
flour. In this case, the reaction was followed over time to
monitor the hydrolysis of the isoflavone glucosides and aliquots
were taken from the biotransformation at time 0 and after
15 min, 30 min, 1 h, 3 h, 24 h and 48 h. The evolution in the
hydrolysis rate achieved by AheGH1 is represented in Figure 7.
After 15 minutes of incubation, almost no isoflavone gluco-
sides remained in the mixture, matching what had been
observed with the pure standards. However, the amount of
aglycons in the sample treated with AheGH1 continued to
increase as the incubation time progresses. Concurrently, a
decrease in two additional peaks was observed, which matched
the standards malonyl daidzin and malonyl genistin (Figur-
es S8–S13). The hydrolytic capacity of AheGH1 had initially only
been evaluated towards the 7-O-β-d-glucosides daidzin, glycitin
and genistin. After quantification, the increase in aglycons
closely matched the decrease observed for the malonyl-gluco-
sides (Figure 7), confirming that the enzyme was also capable of
hydrolysing this form, albeit at a slower rate.
Conclusions
The extremozyme AheGH1 was successfully cloned, purified and
characterised. Its performance was tested under different
conditions usually found in industrial food processes such as
glucose, fructose, different co-solvents, broad range of temper-
atures and pH values showing promising results. The enzyme
showed good tolerance to sugar (glucose and fructose) along
with excellent performance in the presence of organic solvents,
in particular ethanol. AheGH1 also exhibited wide pH stability
and broad thermostability, making of it an outstanding
candidate for its application in the food industry.
As a particular example, the evaluation of the hydrolytic
capacity of AheGH1 towards the most common isoflavone
glucosides found in soybeans, concluded that the enzyme can
efficiently convert isoflavone glucosides into aglycones, and
hence, it constitutes a promising candidate for the enzymatic
production of soybean isoflavones.
Experimental Section
Chemicals and materials: Commercially available reagents, organic
solvents, and media were purchased from ACROS Organics,
ThermoFisher Scientific, Merck, or Sigma-Aldrich. The synthetic
gene was purchased from Thermo Fisher Scientific and plasmid
DNA purification kit from Macherey-Nagel. DNA ladder, protein
marker and restriction were purchased from New England Biolabs.
Soybean flour and isoflavone standards were purchased from Merck
and Carbosynth.
Discovery of Ahe sequence: A protein BLAST search was performed
using the sequence of the halophilic β-glucosidase BglA from
Halothermothrix orenii[43,44] against the Alicyclobacillus genera. BglA
was used as model protein for its excellent activity and stability on
a broad variety of conditions. Alicyclobacillus genera was selected
because of its acidophilic properties. Candidate sequences from
different Alicyclobacillus species were obtained, and Ahe was
selected for showing better tolerance to acidic pH.
Microbial strains and plasmids: The synthetic gene coding for A.
herbarius β-GH1 (AheGH1), with restriction enzymes BamHI and
HindIII flanking the sequences as restriction sites, was codon
optimised for E. coli and then ordered from GeneArt (ThermoFisher)
in pMA, a commercial cloning vector. The gene was digested with
BamHI and HindIII and ligated into pCH93b, an expression vector
Figure 6. Enzymatic hydrolysis of 3 glucosides: daidzin, glycitin and genistin
at t=0 and after 15 min of reaction at 30 °C. Error bars represent standard
deviations (n=3).
Figure 7. Hydrolysis reaction over soybean isoflavones glucosides at t=0
and after 15 min, 30 min, 1 h, 3 h, 24 h and 48 h at 30 °C when AheGH1 is
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produced in-house,[45] which includes a C-terminal poly-His tag for
purification. E. coli strain XL10-Gold harbouring the plasmid was
grown at 37 °C in LB medium supplemented with ampicillin
(0.1 mgmL  1). The gene was sequenced to confirm that the cloning
was successful.
Expression and purification: Cells of E. coli BL21(DE3) harbouring
the recombinant plasmid were grown at 37 °C in LB medium
supplemented with ampicillin (0.1 mgmL  1). When the OD600 was
between 0.6–0.8, isopropyl β-d-1-thiogalactopyranoside (1 mM)
was added to induce protein expression and the culture was left at
30 °C overnight. Cells were harvested at 4500g, 4 °C, 20 min and the
pellet stored at   20 °C until purification.
The cell pellet was resuspended in buffer (HEPES (50 mM), sodium
chloride (150 mM), imidazole (10 mM), pH 7.5) and cells were
broken by sonication (6 min cycle, 5 s on, 5 s off, 50% amplitude, 1=4
inch probe, Fisherbrand™ Model 120 Sonic Dismembrator). The
lysate was collected by centrifugation for 1 h at 14500g and 4 °C,
and the pellet was discarded.
The supernatant was then filtered through PES 0.45 μm filters
before loading it onto a IMAC column previously loaded with NiSO4
0.1 M and washed with loading buffer (HEPES (50 mM), sodium
chloride (150 mM), imidazole (10 mM), pH 7.5). The column was
washed with loading buffer until a plateau in the UV280 absorbance
was reached. Low affinity binding proteins were eluted using a step
gradient 10% elution buffer and the protein of interest was eluted
using 100% elution buffer (HEPES (50 mM), sodium chloride
(150 mM), imidazole (300 mM), pH 7.5). The purified enzyme was
dialysed overnight. Protein quantification was performed by
measuring absorbance at 220, 250 and 280 nm using a BioTek
Take3 Microplate reader using predicted extinction coefficients
(54854.15 Da, 108415 M  1 cm  1).[23]
Gel filtration: Gel filtration chromatography was performed on a
Superdex 200 10/300 GL column (GE Healthcare), using a mobile
phase consisting of Tris·HCl (50 mM), KCl (100 mM), pH 7.5. Injection
volume: 750 μL, flow rate 0.75 mLmin  1. Samples were prepared to
a final protein concentration of approximately 1 mgmL  1. A
calibration curve was generated using the Sigma-Aldrich Gel
Filtration Markers Kit for Protein Molecular Weights 12000–
200000 Da (MWGF200).
Thermal-shift assay: 6 μL of AheGH1 (8.8 mgmL  1) was mixed with 9
μL SYPRO™ Orange Protein Stain (Sigma-Aldrich) solution (pre-
pared by diluting 0.7 μL in 250 μL water). Thermal-shift assays were
carried out using the MiniOpticon Real-time thermocycler (Bio-rad),
over a temperature gradient of 15–99 °C, increasing at a rate of
2 °Cmin  1. The final melting temperature (Tm) was calculated from
the derivative of each sigmoidal, melting curve, as an average of
quadruple values.
Crystallisation of AheGH1: AheGH1 crystals were grown using the
sitting drop vapour diffusion technique, using an Orxy4 crystallisa-
tion robot (Douglas Instruments). Briefly, 400 nL drops comprising
10 mgmL  1 AheGH1, in 10 mM HEPES pH 7.5, 100 mM NaCl. Drops
were set up in three-drop, round CrystalQuick 96-well plates
(Greiner Bio-One). Each reservoir contained 100 μL of 96 different
crystallisation conditions from the PACT Premier screen (Molecular
Dimensions). AheGH1 crystals grew after 5 days in condition F2
(0.2 M NaBr, 20% (w/v) PEG 3350, 0.1 M Bis Tris Propane pH 6.5, at
room temperature. Crystals were cryoprotected 0.1 M Bis Tris
propane pH 6.5, 30% (w/v) PEG 3350 and 30% ethylene glycol
cryocooled in liquid nitrogen.
Data collection and 3D structure determination of AheGH1: X-ray
diffraction data were collected on the I04 beamline at the Diamond
Light Source (DLS Didcot, UK). Diffraction data were reduced using
XDS[46] and anisotropically truncated and scaled with STARANISO.[47]
Data collection statistics are reported in Table S1.
The structure was solved by molecular replacement using
MOLREP[48] from the CCP4 suite using the crystal structure of a
thermostable β-glucosidase from H. orenii as a search model (PDB
ID: 4PTV.[49] The model was further built using Coot[50] and refined
using phenix.refine[51] and BUSTER.[52] Water molecules were added
using ARP/wARP suite[53] and manually inspected in Coot. The final
model was inspected and validated with MolProbity.[54] Coordinates
and structure factors of the AheGH1 have been deposited in the
Protein Data Bank (www.rscb.org) with accession code 6YN7.
Activity assay and kinetics: Standard β-glucosidase activity was
determined spectrophotometrically using 10 mM p-nitrophenyl-β-
d-glucopyranoside (pNPG) at 25 °C. 10 μL of a suitable enzyme
dilution was added to a 96-well plate per triplicate. Immediately
before the assay, 0.29 mL of the reaction solution HEPES (50 mM),
pNPG (10 mM), pH 7.4 were added and the p-nitrophenol formation
was followed at 420 nm for 10 min. The specific activity [Umg  1]
was expressed as μmol of product formed per minute per milligram
of protein. The extinction coefficient used for the p-nitrophenol was
calculated to be 8.64 mM  1cm  1.
To measure the kinetic properties of the studied enzyme, different
concentrations of the substrate were used, and the enzymatic
activity was measured using the same method as in the standard








by using GraphPad Prism 8.
Synthetic isoflavones standards
Stock solutions: Stock solutions for the β-glucoside isoflavones
(daidzin, glycitin and genistin) and for the aglycon isoflavones
(daidzein, glycitein and genistein) were prepared from authentic
samples (1 mg/mL in ethanol for daidzin, daidzein and genistein
and 1 mgmL  1 in DMSO for genistin, glycitin and glycitein).
Calibration solutions were prepared by dilution of the main stock
solutions.
Enzymatic reaction: Prior to the testing of the enzyme in the real
matrix, a solution containing the three main isoflavone glucosides
present in soybeans (daidzin, genistin and glycitin) was prepared in
triplicate. 100 μL sample containing the three isoflavones gluco-
sides (150 μgmL  1 final concentration) and the enzyme
(0.05 mgmL  1 final concentration) were left in agitation at 30 °C for
15 min. After that time, 450 μL of ACN were added to stop the
enzymatic reaction and 450 μL of distilled water were added to top
up until 1 mL total volume. The samples were then analysed by
HPLC.
Isoflavone extraction from soybean flour: 1 g of soybean flour was
weighed out and suspended in 4 mL of ethanol and 16 mL of
distilled water. The sample was then sonicated for 20 min (5 s on,
5 s off, 60% amplitude, 1=4 inch probe, Fisherbrand™ Model 120
Sonic Dismembrator) centrifuged for 30 min at 4500g and filtered
using a 0.45 μm filter.
Enzymatic biotransformation: After the extraction, 0.5 mgmL  1 of
AheGH1 were added to a tube containing 3 mL of soybean
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30 °C. To follow the progress of the biotransformation, 100 μL
aliquots were taken from the sample after 15 min, 30 min, 1 h, 3 h,
24 h and 48 h and transferred to HPLC vials. 450 μL of ACN and
450 μL of distilled water were added to stop the enzymatic
reaction. The samples were then filtered (0.45 μm) and analysed by
HPLC.
Reversed-phase HPLC analysis of conversions: Samples were analysed
using a ThermoFisher Ultimate 3000 Reverse-phase HPLC (diode
array detector) on a Waters XBridge C18 column (3.5 μm, 2.1×150
mm) with the following method: A: 0.1% TFA in water, B: 0.1% TFA
in acetonitrile. Gradient: 0 min 95% A 5% B; 1 min 95% A 5% B; 5
min 5% A 95% B; 5.10min 0% A 100% B; 6.60 min 0% A 100% B;
7 min 95% A 5% B; 10 min 95% A 5% B. Injection volume 2 μL, at
45 °C with a flow rate of 0.8 mL/min. Retention times in minutes:
daidzin (3.17), glycitin (3.22), genistin (3.40), malonyl-daidzin (3.44),
malonyl-genistin (3.62), daidzein (3.76), glycitein (3.82), genistein
(4.04).
Conversions were calculated from a calibration curve of authentic
standards. Peak areas were manually integrated, and the correlation
coefficients were obtained using the Microsoft Excel® linear
regression model application.
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Tough guy: Enzymatic characterisa-
tion showed that a β-glycosidase from
Alicyclobacillus herbarius was stable
over a broad range of pH values and
temperatures, also exhibiting
excellent tolerance to sugars and
organic solvents, specially to ethanol.
The enzyme was applied in the hy-
drolysis of isoflavone glucosides in an
ethanolic extract of soy flour with out-
standing results.
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